Advanced technologies are helping researchers identify environmental contaminants that could potentially be contributing to ...

The following articles authored by Sara Tolaney, from Dana-Farber Cancer Institute (DFCI), were published in journals included in the Nature Index in 2024. Adjuvant Trastuzumab Emtansine Versus ...

A phase 1 study aiming to test tolerability of combination therapy with trastuzumab deruxtecan and olaparib in Human Epidermal Growth Factor Receptor 2 (HER2)-expressing malignancies—including ovarian ...

Aditxt, Inc. (Nasdaq: ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced that its precision oncology subsidiary, Ignite ...

Boston, MA — Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new ...

Dana-Farber Cancer Institute held its annual Palm Beach Leadership dinner on March 5. The event, chaired by Phyllis Krock, Nancy Gibson and Craig Gibson, recognized top-tier donors and highlighted the ...

Putting in the miles to help with the fight against cancer. A West Hartford couple will be running in the Boston Marathon to ...

Dana-Farber Cancer Institute experts have commented on a Spanish study linking the herbicide picloram to early-onset colorectal cancer, stressing that proof of causality and biological mechanisms is ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...